Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
about
How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagIntrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to considerHow, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.Genetic testing in women with breast cancer: implications for treatment.Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
P2860
Q34354159-82B39170-D784-48A9-BDA1-6BB2312B7A8CQ36884609-82D65B2A-20C2-417B-91B9-A1126AA532BCQ37427226-3D927218-B8B2-4C27-BE51-17EA3F6FA736Q37601478-CF665557-E352-4F56-AFCE-3ECB9DC4024CQ38929029-07BF2B10-AE1B-4627-9097-ACEF46B8C13EQ39099045-292292F4-FA9C-4039-8D46-510D06F381ADQ39637429-BE523FB0-088F-476A-BB0E-C6FE6A97E79FQ47880061-864C8B39-8311-4147-8812-FDDDE70E7801Q47884776-11389A1E-A649-46D6-BB58-C621D2E12E8DQ48329892-29251C42-F0DE-45C2-809D-D51868B79B7AQ48336651-4861213D-CBDB-433E-9A1D-9505556D3AF3Q54257613-795774CD-FC39-4ED3-A422-C86496661429
P2860
Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Getting to the point: what wom ...... tment-focused genetic testing.
@en
Getting to the point: what wom ...... tment-focused genetic testing.
@nl
type
label
Getting to the point: what wom ...... tment-focused genetic testing.
@en
Getting to the point: what wom ...... tment-focused genetic testing.
@nl
prefLabel
Getting to the point: what wom ...... tment-focused genetic testing.
@en
Getting to the point: what wom ...... tment-focused genetic testing.
@nl
P2093
P356
P1476
Getting to the point: what wom ...... tment-focused genetic testing.
@en
P2093
Elvira Zilliacus
Gillian Mitchell
Kaaren Watts
Kristine Barlow-Stewart
Margaret Gleeson
Michelle Peate
P304
P356
10.1188/12.ONF.E101-E111
P577
2012-03-01T00:00:00Z